论文部分内容阅读
目的观察不同分娩方式中第三产程应用卡孕栓预防产后出血的疗效。方法 160例分娩产妇中分别采用阴道分娩80例,剖宫产60例,中期引产20例,随机分为对照组和观察组,每组80例。每组中阴道分娩40例,剖宫产30例,中期引产10例。对照组常规在胎儿分娩后立即给予缩宫素10 U入壶,观察组在此基础上加用卡孕栓1 mg置入阴道内(剖宫产产妇为舌下含服)。分别比较两组第三产程时间、产后2 h出血量、产后出血发生率及药物不良反应。结果阴道分娩、中期引产的观察组第三产程时间、产后2 h出血量及产后出血发生率明显少于对照组(P<0.05);剖宫产的观察组产后2 h出血量及产后出血发生率明显少于对照组(P<0.05)。两组不良反应比较差异无统计学意义(P>0.05)。结论第三产程早期应用卡孕栓可以缩短第三产程,减少产后出血,可在临床进一步推广应用。
Objective To observe the curative effect of using carbamazepine to prevent postpartum hemorrhage in the third stage of labor in different modes of delivery. Methods 160 cases of childbirth were adopted vaginal delivery in 80 cases, 60 cases of cesarean section, induced abortion in 20 cases, were randomly divided into control group and observation group, 80 cases in each group. Vaginal delivery in each group 40 cases, 30 cases of cesarean section, mid-term induction of labor in 10 cases. The control group routinely given oxytocin 10 U into the pot after the fetus was delivered. On the basis of this, the observation group was treated with carbamazepine 1 mg intravaginally (cesarean section was sublingual). The duration of the third stage of labor, the amount of bleeding 2 h after delivery, the incidence of postpartum hemorrhage and adverse drug reactions were compared between the two groups. Results The duration of the third stage of labor, the amount of hemorrhage 2 h postpartum and the incidence of postpartum hemorrhage in the vaginal delivery and mid-term labor induction groups were significantly less than those in the control group (P <0.05). The bleeding volume and postpartum hemorrhage Significantly less than the control group (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion The early application of carbamazepine in the third stage of labor can shorten the third stage of labor and reduce postpartum hemorrhage, which can be further popularized and applied in clinic.